134 related articles for article (PubMed ID: 35261355)
1. Solitary Nasopharyngeal Metastasis From Papillary Thyroid Carcinoma Shown on FDG PET/CT.
Xu A; Jie X; Xiu Y; Shi H
Clin Nucl Med; 2022 May; 47(5):e425-e427. PubMed ID: 35261355
[TBL] [Abstract][Full Text] [Related]
2. Two Cases of Synchronous Hodgkin Lymphoma and Papillary Thyroid Carcinoma in 18 F-FDG PET/CT.
Wang R; Cai H; Liu C; Lv Z; Ma C
Clin Nucl Med; 2024 Jul; 49(7):650-651. PubMed ID: 38689445
[TBL] [Abstract][Full Text] [Related]
3. Brain-Only Metastases Seen on FDG PET as First Relapse of Papillary Thyroid Carcinoma Two Years Post-Thyroidectomy.
Naddaf SY; Syed GM; Hadb A; Al-Thaqfi S
Clin Nucl Med; 2016 Sep; 41(9):693-4. PubMed ID: 27405041
[TBL] [Abstract][Full Text] [Related]
4. 18F-FDG PET/CT demonstration of a liver metastasis in a patient with papillary thyroid cancer.
Mosci C; McDougall IR; Jeffrey RB; Iagaru A
Clin Nucl Med; 2012 Sep; 37(9):e234-6. PubMed ID: 22889801
[TBL] [Abstract][Full Text] [Related]
5. Endotracheal Leiomyoma Mimicking Malignancy on 18F-FDG PET/CT in a Patient With Papillary Thyroid Carcinoma.
Hwang JP; Lee SW; Kwak JJ; Park JM
Clin Nucl Med; 2017 Sep; 42(9):e403-e404. PubMed ID: 28639955
[TBL] [Abstract][Full Text] [Related]
6. Intravenous Tumor Thrombus From Papillary Carcinoma of Thyroid Demonstrated by 18F-FDG PET/CT.
Wang Y; Jiang L; Zhang X; Xu Y; Liu B
Clin Nucl Med; 2022 Jun; 47(6):541-542. PubMed ID: 35025802
[TBL] [Abstract][Full Text] [Related]
7. Pancreatic metastasis from papillary thyroid carcinoma: Case report and literature review.
Stein R; Harmon TS; Harmon CE; Kuo E; Ozdemir S
Hell J Nucl Med; 2021; 24(2):140-148. PubMed ID: 34352049
[TBL] [Abstract][Full Text] [Related]
8. 18F-FDG PET/CT of Papillary Carcinoma in a Lateral Thyroglossal Duct Cyst.
Sachpekidis C; Dettmer MS; Weidner S; Giger R; Wartenberg J
Clin Nucl Med; 2017 Aug; 42(8):e371-e374. PubMed ID: 28525461
[TBL] [Abstract][Full Text] [Related]
9. Feasibility of FDG-PET/CT for the initial diagnosis of papillary thyroid cancer.
Kim H; Na KJ; Choi JH; Ahn BC; Ahn D; Sohn JH
Eur Arch Otorhinolaryngol; 2016 Jun; 273(6):1569-76. PubMed ID: 25971994
[TBL] [Abstract][Full Text] [Related]
10. Prognostic implication of fluorine-18 fluorodeoxyglucose positron emission tomography/computed tomography in patients with recurrent papillary thyroid cancer.
Kang JH; Jung DW; Pak KJ; Kim IJ; Kim HJ; Cho JK; Shin SC; Wang SG; Lee BJ
Head Neck; 2018 Jan; 40(1):94-102. PubMed ID: 29130586
[TBL] [Abstract][Full Text] [Related]
11. Metastatic Papillary Thyroid Cancer Mimicking Hypopharyngeal Carcinoma.
Du B; Wang S; Liu Y; Li Y; Li X
Clin Nucl Med; 2023 Jan; 48(1):90-91. PubMed ID: 36469069
[TBL] [Abstract][Full Text] [Related]
12. Detection of intraluminal tracheal metastasis of thyroid papillary carcinoma by 18F-FDG PET/CT.
Ozkan E; Araz M; Soydal C; Kucuk NO; Ibis E
Clin Nucl Med; 2012 Jun; 37(6):e160-1. PubMed ID: 22614217
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathological characteristics including BRAF V600E mutation status and PET/CT findings in papillary thyroid carcinoma.
Choi EK; Chong A; Ha JM; Jung CK; O JH; Kim SH
Clin Endocrinol (Oxf); 2017 Jul; 87(1):73-79. PubMed ID: 28329426
[TBL] [Abstract][Full Text] [Related]
14. Asymptomatic solitary cerebral metastasis from papillary carcinoma thyroid: 131I SPECT/CT for accurate staging.
Jain TK; Karunanithi S; Sharma P; Vijay MK; Ballal S; Bal C
Clin Nucl Med; 2014 Nov; 39(11):977-9. PubMed ID: 24566406
[TBL] [Abstract][Full Text] [Related]
15. Fluorodeoxyglucose-positron emission tomography scan-positive recurrent papillary thyroid cancer and the prognosis and implications for surgical management.
Schreinemakers JM; Vriens MR; Munoz-Perez N; Guerrero MA; Suh I; Rinkes IH; Gosnell J; Shen WT; Clark OH; Duh QY
World J Surg Oncol; 2012 Sep; 10():192. PubMed ID: 22985118
[TBL] [Abstract][Full Text] [Related]
16. Nasopharyngeal low-grade papillary schneiderian carcinoma with cervical metastasis.
Uraguchi K; Nishida K; Makino T; Makihara S; Tabata M; Kariya S; Ando M
Auris Nasus Larynx; 2023 Oct; 50(5):821-826. PubMed ID: 36585284
[TBL] [Abstract][Full Text] [Related]
17. Role of Thyroglobulin Doubling Time in Differentiated Thyroid Cancer and Its Relationship with Demographic-Histopathologic Risk Factors and
Araz M; Soydal Ç; Özkan E; Akkuş P; Nak D; Küçük NÖ; Kır KM
Cancer Biother Radiopharm; 2021 Jun; 36(5):425-432. PubMed ID: 32379488
[No Abstract] [Full Text] [Related]
18. F18-fluorodeoxyglucose positron emission tomography in detecting metastatic papillary thyroid carcinoma with elevated human serum thyroglobulin levels but negative I-131 whole body scan.
Hung MC; Wu HS; Kao CH; Chen WK; Changlai SP
Endocr Res; 2003 May; 29(2):169-75. PubMed ID: 12856803
[TBL] [Abstract][Full Text] [Related]
19. Factors associated with positive F-18 flurodeoxyglucose positron emission tomography before thyroidectomy in patients with papillary thyroid carcinoma.
Kim BS; Kim SJ; Kim IJ; Pak K; Kim K
Thyroid; 2012 Jul; 22(7):725-9. PubMed ID: 22524470
[TBL] [Abstract][Full Text] [Related]
20. Postoperative fluorine-18-fluorodeoxyglucose positron emission tomography/computed tomography: an important imaging modality in patients with aggressive histology of differentiated thyroid cancer.
Nascimento C; Borget I; Al Ghuzlan A; Deandreis D; Hartl D; Lumbroso J; Berdelou A; Lepoutre-Lussey C; Mirghani H; Baudin E; Schlumberger M; Leboulleux S
Thyroid; 2015 Apr; 25(4):437-44. PubMed ID: 25633259
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
